{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:51:02Z","timestamp":1794009062874,"version":"4.8.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Invasive meningococcal disease (IMD) is an unpredictable and severe infection caused by <jats:italic toggle=\"yes\">Neisseria meningitidis<\/jats:italic>. Its case fatality rate could vary from 9.7% to 26% and up to 36% of survivors may experience long-term sequelae, representing a challenge for public health.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aimed:<\/jats:title>\n            <jats:p>To describe the sequelae at hospital discharge caused by IMD in children between years 2009\u20132019.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Cross-sectional study performed in 2 pediatric hospitals. Patients with microbiologically confirmed diagnosis of IMD from 2009 to 2019 were included. Bivariate and logistic regression analysis were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The records of 61 patients were reviewed and included. Sixty-seven percent were male, median age 9 months (interquartile range 4\u201327), 72% were admitted to intensive care unit. Thirty-seven (60.5%) had at least 1 sequela (75% and 37% in patients with or without meningitis, respectively). The most frequents sequelae were neurological 72%, hearing loss 32%, and osteoarticular 24%. Significant differences were found comparing patients with and without sequelae: drowsiness 67.6% versus 41.7% (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04), irritability 67.6% versus 25% (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01), meningeal signs 62.2% versus 29.2% (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01). In logistic regression analysis, postdischarge follow-up had OR 21.25 (95% confidence intervals [CI]: 4.93\u201391.44), irritability had OR 8.53 (95% CI: 1.64\u201344.12), meningeal signs had OR 8.21 (95% CI: 0.71\u201394.05), invasive mechanical ventilation had OR 8.23 (95% CI: 0.78\u201385.95), meningitis plus meningococcemia OR 1.70 (95% CI: 0.18\u201315.67) to have sequelae, while children with meningococcemia and vomiting had a OR 0.04 (95% CI: 0.00\u20130.36) and OR 0.27 (95% CI: 0.03\u20132.14), respectively. <jats:italic toggle=\"yes\">N. meningitidis<\/jats:italic> serogroup W (MenW) was isolated in 54.1% (33\/61), and <jats:italic toggle=\"yes\">N. meningitidis<\/jats:italic> serogroup B (MenB) in 31.1% (19\/61) of cases. A significant difference was found in osteoarticular sequelae (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.05) between MenB and MenW. There was a decrease in cases after the meningococcal conjugate vaccine against serogroups A, C, W and Y was implemented (2015\u20132019).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>IMD remains as a public health concern. A high rate of sequelae was found in pediatric patients in our series, even in the clinical manifestations other than meningitis. Neurological sequelae were the most prevalent. Multidisciplinary follow-up protocols to reduce long-term impact must be urgently established to assess all children with IMD<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003560","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T19:00:09Z","timestamp":1649962809000},"page":"607-613","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Sequelae at Hospital Discharge in 61 Children With Invasive Meningococcal Disease, Chile, 2009\u20132019"],"prefix":"10.1097","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4626-3629","authenticated-orcid":false,"given":"Cindy","family":"Arteta-Acosta","sequence":"first","affiliation":[{"name":"Postgraduate Department, Doctorate in Health Science with Pediatrics Specialty, Universidad de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-1387","authenticated-orcid":false,"given":"Rodolfo","family":"Villena Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Universidad de Chile, Santiago, Chile"},{"name":"Infectious Diseases Unit, Hospital de ni\u00f1os Dr. Exequiel Gonz\u00e1lez Cort\u00e9s, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Santolaya de Pablo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Universidad de Chile, Santiago, Chile"},{"name":"Infectious Diseases Unit, Hospital de ni\u00f1os Dr. Luis Calvo Mackenna, Chile."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"e024343","DOI":"10.1136\/bmjopen-2018-024343","article-title":"Serogroup-specific meningococcal carriage by age group: a systematic review and meta-analysis.","volume":"9","author":"Peterson","year":"2019","journal-title":"BMJ Open"},{"issue":"2 suppl","key":"R2-20250614","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jadohealth.2016.04.012","article-title":"The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines.","volume":"59","author":"Pelton","year":"2016","journal-title":"J Adolesc Health"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijid.2019.05.006","article-title":"Epidemiological burden of meningococcal disease in Latin America: a systematic literature review.","volume":"85","author":"Vespa Presa","year":"2019","journal-title":"Int J Infect Dis"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"103571","DOI":"10.1016\/j.micpath.2019.103571","article-title":"Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: a systematic review and meta-analysis.","volume":"134","author":"Purmohamad","year":"2019","journal-title":"Microb Pathog"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4067\/S0034-98872019000600776","article-title":"Plan de acci\u00f3n nacional frente a la emergencia de la cepa W-135 responsable de enfermedad meningoc\u00f3cica invasora en Chile, 2012-2013.","volume":"147","author":"Valenzuela","year":"2019","journal-title":"Rev M\u00e9dica Chile"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","article-title":"The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination.","volume":"81","author":"Parikh","year":"2020","journal-title":"J Infect"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1016\/j.vaccine.2019.09.050","article-title":"Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile.","volume":"37","author":"Villena","year":"2019","journal-title":"Vaccine"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.vaccine.2021.11.075","article-title":"Invasive meningococcal disease in Chile seven years after ACWY conjugate vaccine introduction.","volume":"40","author":"Villena","year":"2022","journal-title":"Vaccine"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.apjtm.2017.10.004","article-title":"Meningococcal disease, a clinical and epidemiological review.","volume":"10","author":"Batista","year":"2017","journal-title":"Asian Pac J Trop Med"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1474-4422(12)70180-1","article-title":"Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study.","volume":"11","author":"Viner","year":"2012","journal-title":"Lancet Neurol"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1001\/jama.2013.3792","article-title":"Educational achievement and economic self-sufficiency in adults after childhood bacterial meningitis.","volume":"309","author":"Roed","year":"2013","journal-title":"JAMA"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40121-018-0213-2","article-title":"Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers.","volume":"7","author":"Olbrich","year":"2018","journal-title":"Infect Dis Ther"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/21645515.2015.1010885","article-title":"Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country.","volume":"11","author":"Izquierdo","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1542\/peds.106.3.505","article-title":"Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome.","volume":"106","author":"Alpern","year":"2000","journal-title":"Pediatrics"},{"key":"R17-20250614","first-page":"16","article-title":"Bolet\u00edn de laboratorio y vigilancia al d\u00eda. Vigilancia de laboratorio enfermedad invasora Neisseria meningitidis 2012-2016.","volume":"7","year":"2017"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/INF.0000000000000282","article-title":"The clinical features and long-term sequelae of invasive meningococcal disease in children.","volume":"33","author":"Stein-Zamir","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/INF.0000000000001048","article-title":"The burden of pediatric invasive meningococcal disease in Spain (2008\u20132013).","volume":"35","author":"Rivero-Calle","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/INF.0000000000000043","article-title":"The clinical burden and predictors of sequelae following invasive meningococcal disease in Australian children.","volume":"33","author":"Wang","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","article-title":"Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis.","volume":"10","author":"Edmond","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/cc9087","article-title":"Surviving meningococcal septic shock in childhood: long-term overall outcome and the effect on health-related quality of life.","volume":"14","author":"Buysse","year":"2010","journal-title":"Crit Care"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1542\/peds.2008-0581","article-title":"Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study.","volume":"123","author":"Borg","year":"2009","journal-title":"Pediatrics"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.anpedi.2015.12.001","article-title":"Invasive meningococcal disease in Navarra in the era of a meningococcal C vaccine.","volume":"86","author":"Morales","year":"2017","journal-title":"An Pediatr\u00eda Engl Ed"},{"key":"R25-20250614","article-title":"Outcomes of invasive meningococcal disease in adults and children in canada between 2002 and 2011: A Prospective Cohort Study.","volume":"60","author":"Sadarangani","year":"2015","journal-title":"Clin Infect Di"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/cid\/civ506","article-title":"Disease burden of invasive meningococcal disease in the Netherlands between June 1999 and June 2011: a subjective role for serogroup and clonal complex.","volume":"61","author":"Stoof","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"a012393","DOI":"10.1101\/cshperspect.a012393","article-title":"Pathogenesis of meningococcemia.","volume":"3","author":"Coureuil","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11832-010-0285-3","article-title":"Meningococcal purpura fulminans in children. II: late orthopedic sequelae management.","volume":"4","author":"Nectoux","year":"2010","journal-title":"J Child Orthop"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archotol.132.9.941","article-title":"Clinical predictors for hearing loss in children with bacterial meningitis.","volume":"132","author":"Kutz","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2B","key":"R30-20250614","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/S0004-282X2004000300009","article-title":"Sequelae from meningococcal meningitis in children: a critical analysis of dexamethasone therapy.","volume":"62","author":"Casella","year":"2004","journal-title":"Arq Neuropsiquiatr"},{"key":"R31-20250614","first-page":"54","article-title":"Is bacterial meningitis a risk factor for developing attention deficit hyperactivity disorder.","volume":"54","author":"Hadzic","year":"2017","journal-title":"Isr J Psychiatry"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/adc.85.1.6","article-title":"Neurodevelopmental outcome in meningococcal disease: a case-control study.","volume":"85","author":"Fellick","year":"2001","journal-title":"Arch Dis Child"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/INF.0b013e3181ef25f7","article-title":"Long-term sequelae of childhood bacterial meningitis: an underappreciated problem.","volume":"30","author":"Chandran","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/520303","article-title":"Complications and sequelae of meningococcal disease in Quebec, Canada, 1990\u20131994.","volume":"26","author":"Erickson","year":"1998","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:09:04Z","timestamp":1749946144000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003560","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,13]]}}}